<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Holiday WishList</title>
	<atom:link href="http://www.kehle.com/2005/12/04/holiday-wishlist/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.kehle.com/2005/12/04/holiday-wishlist/</link>
	<description>Notes to Myself</description>
	<lastBuildDate>Mon, 02 Jan 2012 22:29:38 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: melanotan-1 Scenesse</title>
		<link>http://www.kehle.com/2005/12/04/holiday-wishlist/comment-page-1/#comment-136</link>
		<dc:creator>melanotan-1 Scenesse</dc:creator>
		<pubDate>Wed, 02 Jun 2010 01:55:48 +0000</pubDate>
		<guid isPermaLink="false">http://kehle.com/?p=12#comment-136</guid>
		<description>Joel Kehle,

That &quot;Australian company&quot; that you are talking about in this blog entry has gotten approval for melanotan-1 (afamelanotide / Scenesse) in Italy as a medicine to help develop pigmentation in EPP sufferers and thereby prevent the painful burning that from the photosensitivity that their disease brings.

&lt;a href=&quot;http://www.lifescientist.com.au/article/346731/clinuvel_gets_pre-approval_win_italy/&quot; rel=&quot;nofollow&quot;&gt;This is the news about that.&lt;/a&gt;

This may not seem interesting from the get go but it is a big step towards a possible general release of the drug for usage in folks like yourself.</description>
		<content:encoded><![CDATA[<p>Joel Kehle,</p>
<p>That &#8220;Australian company&#8221; that you are talking about in this blog entry has gotten approval for melanotan-1 (afamelanotide / Scenesse) in Italy as a medicine to help develop pigmentation in EPP sufferers and thereby prevent the painful burning that from the photosensitivity that their disease brings.</p>
<p><a href="http://www.lifescientist.com.au/article/346731/clinuvel_gets_pre-approval_win_italy/" rel="nofollow">This is the news about that.</a></p>
<p>This may not seem interesting from the get go but it is a big step towards a possible general release of the drug for usage in folks like yourself.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: melanotan-1 Scenesse</title>
		<link>http://www.kehle.com/2005/12/04/holiday-wishlist/comment-page-1/#comment-135</link>
		<dc:creator>melanotan-1 Scenesse</dc:creator>
		<pubDate>Tue, 25 May 2010 12:21:45 +0000</pubDate>
		<guid isPermaLink="false">http://kehle.com/?p=12#comment-135</guid>
		<description>Does the prospect of a licensed and regulated version of the two melanotan peptides eventually becoming available sound interesting?

melanotan-1 (afamelanotide / Scenesse) has been approved in Italy for treating sufferers of EPP:
http://www.lifescientist.com.au/article/346731/clinuvel_gets_pre-approval_win_italy/

Maybe there is a future for this version after all?</description>
		<content:encoded><![CDATA[<p>Does the prospect of a licensed and regulated version of the two melanotan peptides eventually becoming available sound interesting?</p>
<p>melanotan-1 (afamelanotide / Scenesse) has been approved in Italy for treating sufferers of EPP:<br />
<a href="http://www.lifescientist.com.au/article/346731/clinuvel_gets_pre-approval_win_italy/" rel="nofollow">http://www.lifescientist.com.au/article/346731/clinuvel_gets_pre-approval_win_italy/</a></p>
<p>Maybe there is a future for this version after all?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: melanotan - afamelanotide</title>
		<link>http://www.kehle.com/2005/12/04/holiday-wishlist/comment-page-1/#comment-58</link>
		<dc:creator>melanotan - afamelanotide</dc:creator>
		<pubDate>Sat, 12 Sep 2009 18:12:10 +0000</pubDate>
		<guid isPermaLink="false">http://kehle.com/?p=12#comment-58</guid>
		<description>There&#039;s an excellent article by Wired that is related to this entry:
&lt;a href=&quot;http://www.wired.com/wiredscience/2009/01/tan/&quot; rel=&quot;nofollow&quot;&gt;Suntan Drug Greenlighted for Trials&lt;/a&gt;

Cheers</description>
		<content:encoded><![CDATA[<p>There&#8217;s an excellent article by Wired that is related to this entry:<br />
<a href="http://www.wired.com/wiredscience/2009/01/tan/" rel="nofollow">Suntan Drug Greenlighted for Trials</a></p>
<p>Cheers</p>
]]></content:encoded>
	</item>
</channel>
</rss>

